BioSpace News Archive

Codex DNA, Inc., a pioneer in automated benchtop synthetic biology systems, announced its speaker lineup for presentations at SynBioBeta’s Built with Biology Global Conference, which is being held in Oakland, Calif., on April 12-14, 2022.

Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on oncology and rare diseases, today announced that Dr. Denise Scots-Knight, Chief Executive Officer of Mereo, will participate in a fireside chat at the 21st Annual Needham Virtual Healthcare Conference.

Avadel Pharmaceuticals plc announced today the publication of positive secondary endpoint data from its pivotal Phase 3 REST-ON trial of FT218 in CNS Drugs, a peer-reviewed medical journal focused on the treatment of psychiatric and neurological disorders.

Cabaletta Bio, Inc. announced that Gwendolyn Binder, Ph.D., President of Science and Technology, will present a pre-recorded company presentation at the 21st Annual Needham Virtual Healthcare Conference, which will become available for on-demand viewing on Tuesday, April 12, 2022 at 3:45 p.m. ET.

Merus N.V. announced that Bill Lundberg, M.D., President, Chief Executive Officer of Merus, will participate in a fireside chat at the 21st Annual Needham Virtual Healthcare Conference on Wednesday, April 13 at 10:15-10:55 a.m. ET.

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced the enrollment of the last subject in its ARRECTOR pivotal Phase 3 trial of topical roflumilast foam in adolescents and adults with scalp and body psoriasis.

Dr. Brihad Abhyankar named Vice President of Clinical Development, deeply experienced GI drug development leader Aaron Pelta promoted to Senior Vice President, Business and Corporate Development; leading portfolio, commercial, and partnering strategy.

Asymchem Laboratories Co., Ltd., a leading CDMO serving the global pharmaceutical and biotech industry, announced the company has completed construction of a new building at its Dunhua, China, production site.

Enzychem Lifesciences (KOSDAQ: 183490), a late-stage biopharmaceutical company, announced that it will present new Phase 2 US clinical study data regarding its lead drug candidate, EC-18 for chemoradiation-induced oral mucositis (CRIOM) at the American Society of Clinical Oncology (ASCO) 2022 annual meeting, which will be held in-person on June 3-7th, 2022 in Chicago.

Cybin Inc. is pleased to announce that Doug Drysdale, Cybin’s Chief Executive Officer, will participate in a fireside chat and panel discussion at the Benzinga Psychedelics Capital Conference being held at the Fontainebleau Miami Beach on Tuesday, April 19, 2022.